New Mepirine Tablets (Glymepiride)
Glimepiride
Prescription medication
Daehwa Pharmaceutical Co., Ltd.
MFDS item code 202002765 · Approved 2020.04.20
This product's status changed to Approval withdrawn on 2023.06.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood glucose control in type 2 diabetes
This medication is used to complement dietary and exercise therapy to improve blood glucose control in patients with type 2 diabetes. It can be used alone and may also be administered in combination with insulin when blood glucose control is insufficient with oral hypoglycemics. Additionally, it is used alongside metformin when sulfonylurea medications or metformin monotherapy are not effective, helping to control blood glucose more effectively in various ways and contributing to the prevention of diabetes complications.
This medication is administered orally once daily. It should be taken before breakfast or just prior to the first meal. The initial dose should be 1 mg of glymepiride, which can be increased by 1 mg at intervals of 1 to 2 weeks. Generally, dosages above 4 mg do not provide additional effects, but if necessary, doses of 6 mg or 8 mg may be achievable. If a daily dosage of 4 mg fails, consider insulin therapy.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or diabetic coma. Individuals allergic to this medication or its components should also avoid taking it. There is no experience using this medication in patients with severely impaired liver or kidney function, so switching to insulin therapy is recommended. In pregnant or potentially pregnant women, as well as breastfeeding women, it is safest not to use this medication. Patients with severe infections, those undergoing surgery, or those with significant trauma may require insulin therapy, so caution is necessary. When gastrointestinal disturbances such as diarrhea or vomiting occur, there is a risk of hypoglycemia due to inadequate absorption of food, so care is needed. This medication contains lactose, so individuals with lactose intolerance or related genetic disorders should not take it. During the initial stages of treatment, the risk of hypoglycemia is high, thus blood glucose levels should be monitored closely, especially in the elderly, those with poor nutritional status, or those with irregular eating habits. Imbalances in physical activity and food intake, changes in diet, and alcohol consumption may also increase the risk of hypoglycemia, hence caution is necessary. Patients with impaired liver or kidney function, other endocrine diseases, and those taking multiple medications should consult their doctor as they may have an increased risk of hypoglycemia. This medication contains Yellow No. 4 (tartrazine), so those allergic to this component should use it cautiously. Symptoms of hypoglycemia can include headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness. In severe cases, it may lead to seizures or coma. Transient visual disturbances or blurred vision may occur, and gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea may also appear. Serious side effects like liver dysfunction, blood abnormalities, and allergic reactions may occur rarely, so if any abnormal symptoms arise, medical personnel must be notified immediately. When taking this medication, regular meals, exercise, and weight management are important, and if hypoglycemia occurs, sugars should be consumed immediately to alleviate symptoms. Inform the doctor about all medications being taken, as concomitant use of other drugs may affect blood glucose control. In cases of pregnancy or breastfeeding, this medication may be harmful to the fetus or newborn, so it is advisable not to use it. For children under 18 years of age, safety and efficacy have not been established, so it is recommended not to use it. Elderly patients may experience delayed drug excretion due to reduced kidney function, thus requiring dosage adjustments. In the case of overdose, severe hypoglycemia may occur, requiring immediate medical attention and possibly emergency measures such as glucose injections.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. It is safest to store it at room temperature, between 1°C and 30°C.
Green rectangular tablet
100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride
Prescription medication
Daehwa Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.